Publicaciones (20) Publicaciones de María Teresa Pérez Warnisher

2024

  1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  2. Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer

    ERJ Open Research, Vol. 10, Núm. 1

2022

  1. Learning curves and association of pathologist's performance with the diagnostic accuracy of linear endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA): a cohort study in a tertiary care reference centre

    BMJ Open, Vol. 12, Núm. 10

2021

  1. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

    Frontiers in Immunology, Vol. 12

  2. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  3. Present, past, and future of the connection between SAHS and cancer

    Open Respiratory Archives

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

2019

  1. Obstructive sleep apnea and nocturnal hypoxemia are associated with an increased risk of lung cancer

    Sleep Medicine, Vol. 63, pp. 41-45

  2. Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study

    Sleep Medicine, Vol. 54, pp. 181-186

  3. Sleep disordered breathing is highly prevalent in patients with lung cancer: Results of the sleep apnea in lung cancer study

    Respiration, Vol. 97, Núm. 2, pp. 119-124

  4. Tobacco use worldwide: Legislative efforts to curb consumption

    Annals of Global Health, Vol. 85, Núm. 1

2018

  1. A multicentre, randomized controlled trial of telehealth for the management of COPD

    Respiratory Medicine, Vol. 144, pp. 74-81

  2. Efficacy and costs of telehealth for the management of COPD: The PROMETE II trial

    European Respiratory Journal

  3. Tobacco use worldwide: Legislative efforts to curb consumption

    Annals of Global Health, Vol. 84, Núm. 4, pp. 571-579

2017

  1. Derrame pleural maligno como debut de neoplasia no conocida

    Revista de Patologia Respiratoria, Vol. 20, Núm. 2, pp. 41-46

  2. Development and co-existence of sarcoidosis with lymphoproliferative processes

    Archivos de Bronconeumologia, Vol. 53, Núm. 5, pp. 276-277

  3. Diagnostic accuracy of nasal cannula versus microphone for detection of snoring

    Laryngoscope, Vol. 127, Núm. 12, pp. 2886-2890

2016

  1. El inmunodeprimido, el escondite idóneo para microorganismos oportunistas

    Revista de Patologia Respiratoria, Vol. 19, Núm. 4, pp. 139-142

  2. Reclasificación de la gravedad de la EPOC en función de las guías GOLD y GesEPOC en pacientes hospitalizados por una agudización

    Revista de Patologia Respiratoria, Vol. 19, Núm. 2, pp. 37-43

2015

  1. Linfoma MALT pulmonar asociado a un síndrome de Sjögren

    Revista de Patologia Respiratoria, Vol. 18, Núm. 2, pp. 79-81